Literature DB >> 9409348

The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease.

A Churchyard1, A J Lees.   

Abstract

Severe dementia affects 10 to 20% of all patients with Parkinson's disease (PD) and is particularly common in those aged 65 years and over. In a clinicopathologic study, we correlated Mini-Mental State Examination scores and DSM-III dementia ratings with the density of Lewy bodies, Lewy neurites, neurofibrillary tangles, neuritic plaques, gliosis, and neurons in the hippocampus and amygdala of 27 PD patients without Alzheimer's disease changes. Cortical Lewy body densities were examined in the anterior cingulate gyrus. The degree of cognitive impairment was correlated with the density of Lewy neurites in the CA2 hippocampal field, raising the possibility that disruption of the connection between the dentate gyrus, entorhinal cortex, septal nuclei, and hypothalamus and the CA1 field contributes to dementia in PD.

Entities:  

Mesh:

Year:  1997        PMID: 9409348     DOI: 10.1212/wnl.49.6.1570

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

1.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

Review 2.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

3.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Authors:  Richard A Maki; Michael Holzer; Khatereh Motamedchaboki; Ernst Malle; Eliezer Masliah; Gunther Marsche; Wanda F Reynolds
Journal:  Free Radic Biol Med       Date:  2019-06-06       Impact factor: 7.376

4.  Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents.

Authors:  Andrew B West; Rita M Cowell; João P L Daher; Mark S Moehle; Kelly M Hinkle; Heather L Melrose; David G Standaert; Laura A Volpicelli-Daley
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

5.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Virginia M-Y Lee
Journal:  Nat Protoc       Date:  2014-08-14       Impact factor: 13.491

6.  Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.

Authors:  Neha Shah; Kirk A Frey; Martijn L T M Müller; Myria Petrou; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Roger L Albin; Nicolaas I Bohnen
Journal:  Mov Disord       Date:  2015-09-18       Impact factor: 10.338

7.  Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.

Authors:  Naroa Ibarretxe-Bilbao; Blanca Ramírez-Ruiz; Eduardo Tolosa; María Jose Martí; Francesc Valldeoriola; Nuria Bargalló; Carme Junqué
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

8.  Age-Dependent Specific Changes in Area CA2 of the Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion Syndrome.

Authors:  Rebecca A Piskorowski; Kaoutsar Nasrallah; Anastasia Diamantopoulou; Jun Mukai; Sami I Hassan; Steven A Siegelbaum; Joseph A Gogos; Vivien Chevaleyre
Journal:  Neuron       Date:  2016-01-06       Impact factor: 17.173

Review 9.  Animal models of Parkinson's disease: vertebrate genetics.

Authors:  Yunjong Lee; Valina L Dawson; Ted M Dawson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

10.  Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients.

Authors:  Kevin Duerson; Randall L Woltjer; Paramita Mookherjee; James B Leverenz; Thomas J Montine; Thomas D Bird; David V Pow; Thomas Rauen; David G Cook
Journal:  Brain Pathol       Date:  2008-07-02       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.